Changes in Pulmonary Function and Development of Clinical Radiation Pneumonitis in Breast Cancer Patients following Post Mastectomy Radiation Therapy
DOI:
https://doi.org/10.30683/1927-7229.2020.09.11Keywords:
Breast cancer, Adjuvant radiotherapy, Radiation pneumonitis, Spirometry, CLD.Abstract
Background: Lung is the main organ at risk for radiation induced injury while treating breast cancers with Post Mastectomy Radiotherapy (PMRT). Restrictive lung changes are usually seen in spirometry which tends to normalize by 1 year. Central Lung Distance (CLD) is shown to correlate well with the percentage of ipsilateral lung volume irradiated.
Aims and Objectives: Spirometric changes following Radiation Therapy (RT) to chest wall in breast cancer patients using conventional fractionation and its correlation with acute radiation pneumonitis.
Materials and Methodology: Thirty Breast cancer patients who received RT to chest wall +/- supraclavicular fossa and axilla, following Modified Radical Mastectomy (MRM) and neoadjuvant or adjuvant chemotherapy using tangential beams with Co60 teletherapy to a dose of 50 Gray in conventional fractionation were included and followed up till 6 months post RT. Baseline chest X-ray and spirometry done pre-RT were compared with those taken at 1, 3 and 6 months after completion of RT. Patients were evaluated at each visit for signs and symptoms of radiation pneumonitis, when present were graded as per Radiation Therapy Oncology Group (RTOG) criteria.
Results: There was a significant fall in Forced Vital Capacity (FVC) by the end of 3 months (p value <0.01) which improved by 6 months without any active intervention in 95% of the patients. Mean baseline FVC was 83% which decreased to 70% by the end of 3 months and 79% at 6 months. Forced Expiratory Volume in first second (FEV1) and FEV1/FVC did not show any significant change compared to baseline. Spirometric changes correlated with reversible restrictive lung changes. One out of 30 patients developed symptomatic acute radiation pneumonitis (5%) of grade 3 severity who had moderate restrictive lung disease.
Conclusion: Significant decrease in FVC of the lungs is present following PMRT in carcinoma of breast patients in the initial 3 months which tends to normalize by 6 months. 5% of the patients develop symptomatic acute lung toxicity which can be further reduced by minimizing the irradiated lung volume.
References
American Cancer Society: Cancer Facts and Figures 2020. Atlanta, Ga: American Cancer Society, 2020.
Ragaz J, Olivotto I, Wilson K, Spinelli J, Durand R. Locoregional Radiation Therapy in Patients With High-Risk Breast Cancer Receiving Adjuvant Chemotherapy: 20-Year Results of the British Columbia Randomized Trial. JNCI Journal of the National Cancer Institute 2005; 97(15): 1163-1164. https://doi.org/10.1093/jnci/dji217
Truong P. Clinical practice guidelines for the care and treatment of breast cancer: Locoregional post- mastectomy radiotherapy. Canadian Medical Association Journal 2004; 170(8): 1263-1273. https://doi.org/10.1503/cmaj.1031000
Ghafoori P, Marks L, Vujaskovic Z, Kelsey C. Radiation-Induced Lung Injury: Assessment, Management, and Prevention. Review article- Physicians Practice 2008.
Movsas B, Raffin TA, Epstein AH, et al. Pulmonary radiation injury. Chest 1997; 111: 1061-1076. https://doi.org/10.1378/chest.111.4.1061
Fleckenstein K, Zgonjanin L, Chen L, et al. Temporal Onset of Hypoxia and Oxidative Stress After Pulmonary Irradiation. International Journal of Radiation Oncology Biology Physics 2007; 68(1): 196-204. https://doi.org/10.1016/j.ijrobp.2006.12.056
Lind P, Marks L, Hardenbergh P, Clough, R et al. Technical factors associated with radiation pneumonitis after local ± regional radiation therapy for breast cancer. International Journal of Radiation Oncology Biology Physics 2002; 52(1): 137-143. https://doi.org/10.1016/S0360-3016(01)01715-1
Choi Y, Munden R, Erasmus J, et al. Effects of Radiation Therapy on the Lung: Radiologic Appearances and Differential Diagnosis1. Radio Graphics 2004; 24(4): 985-997. https://doi.org/10.1148/rg.244035160
Lund MB, Myhre KL, Mdsom H. The effect on pulmonary function of tangential field technique in radiotherapy for carcinoma of the breast. B J R 1991; 64: 520-3. https://doi.org/10.1259/0007-1285-64-762-520
Price A, Jack W, Kerr G, et al. Acute radiation pneumonitis after postmastectomy irradiation: Effect of fraction size. Clinical Oncology 1990; 2(4): 224-229. https://doi.org/10.1016/S0936-6555(05)80173-6
Kimsey FC, Mendenhall NP, Ewald LM, et al. Is radiation treatment volume a predictor for acute or late effect on pulmonary function? A prospective study of patients treated with breast- conserving surgery and postoperative irradiation. Cancer 1994; 73: 2549-55. https://doi.org/10.1002/1097-0142(19940515)73:10<2549::AID-CNCR2820731016>3.0.CO;2-N
Jeba J. Radiation Pneumonitis After Conventional Radiotherapy For Breast Cancer: A Prospective Study. JCDR 2015; Vol-9(7): XC01-XC05. https://doi.org/10.7860/JCDR/2015/13969.6211
EUSOMA - GUIDELINES AND PUBLICATIONS - The curative role of radiotherapy in the treatment of operable breast cancer. [Internet]. Eusoma.org 2015 [cited 7 January 2015]. http://www.eusoma.org/Engx/Guidelines/Other/ OtherRT.aspx?cont=RT_6_3.
Budach W, Bolke E, Kammers K, et al. Adjuvant radiation therapy of regional lymph nodes in breast cancer – a meta-analysis of randomized trials-an update. Radiat Oncol 2015; 10: 258. https://doi.org/10.1186/s13014-015-0568-4
Img.medscape.com. Radiation pneumonitis [Internet] 2015 [cited 17 September 2015]. Available from: http://img. medscape.com/fullsize/migrated/455/711/smj455711.fig3.jpg.
Wennberg B, Gagliardi G, Sundbom L, et al. Early response of lung in breast cancer irradiation: radiologic density changes measured by CT and symptomatic radiation pneumonitis. Int J Radiat Oncol Biol Phys 2002; 52: 1196- 206. https://doi.org/10.1016/S0360-3016(01)02770-5
Kahán Z, Csenki M, Varga Z, et al. The Risk of Early and Late Lung Sequelae After Conformal Radiotherapy in Breast Cancer Patients. International Journal of Radiation Oncology Biology Physics 2007; 68(3): 673-681. https://doi.org/10.1016/j.ijrobp.2006.12.016
Gagliardi G, Bjöhle J, Lax I, et al. Radiation pneumonitis after breast cancer irradiation: analysis of the complication probability using the relative seriality model. International Journal of Radiation Oncology Biology Physics 2000; 46(2): 373-381. https://doi.org/10.1016/S0360-3016(99)00420-4
Chakraborty A, Sharma SC, Behera D, et al. Effect of radiation on pulmonary functions in patients with breast cancer. Indian J Chest Dis and Allied Sci 1991; 33: 195-200.
Ooi GC, Kwong DL, Ho JC, et al. Pulmonary sequelae of treatment for breast cancer: A prospective study. Int J Radiat Oncol Biol Phys 2001; 50: 411-19. https://doi.org/10.1016/S0360-3016(01)01438-9
Tokatli F, Kaya M, Kocak Z, et al. Sequential pulmonary effects of radiotherapy detected by functional and radiological end points in women with breast cancer. Clin Oncol (R Coll Radiol) 2005; 17: 39-46. https://doi.org/10.1016/j.clon.2004.07.012
Krengli M, Sacco M, Loi G, et al. Pulmonary [31] changes after radiotherapy for conservative treatment of breast cancer: a prospective study. Int J Radiat Oncol Biol Phys 2008; 70: 1460-67. https://doi.org/10.1016/j.ijrobp.2007.08.050
Lingos T, Recht A, Vicini F, et al. Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy. International Journal of Radiation Oncology Biology Physics 1991; 21(2): 355-360. https://doi.org/10.1016/0360-3016(91)90782-Y
Yu T, Whitman G, Thames H, et al. Clinically Relevant Pneumonitis After Sequential Paclitaxel-Based Chemotherapy and Radiotherapy in Breast Cancer Patients. JNCI Journal of the National Cancer Institute 2004; 96(22): 1676-1681. https://doi.org/10.1093/jnci/djh315
Downloads
Published
Issue
Section
How to Cite
Similar Articles
- Javier Garde Noguera, Elena Evgenyeva, Mireia Gil Raga, Asunción Juárez Marroquí, Juan Manuel Gasent Blesa, Juan Laforga, Laia Bernet, Mónica Clemente Císcar, Carlos Camps Herrero, Antonio Llombart Cussac, Role of Primary Tumour Resection and Addition of Bevacizumab to Chemotherapy in the Management of Advanced Colorectal Cancer with Inoperable Metastasis: A Retrospective Analysis , Journal of Analytical Oncology: Vol. 2 No. 4 (2013)
- A. Espiau Romera, L. Baquedano Mainar, M.J. Puente Luján, R. Laborda Gotor, L. Ruiz Campo, M.A. Ruiz Conde, Preoperative HE4 Tumor Marker and Prognostic Factors in Endometrial Cancer: Review Article , Journal of Analytical Oncology: Vol. 8 (2019)
- Pavel Barta, Karl Andersson, Frantisek Trejtnar , Jos Buijs , Exploring Time-Resolved Characterization of the Heterogeneity and Dynamics of Ligand-Receptor Interactions on Living Cells , Journal of Analytical Oncology: Vol. 3 No. 2 (2014)
- Robert Skopec, Mutagenesis Associated with DNA-Damage-Stress Response , Journal of Analytical Oncology: Vol. 5 No. 1 (2016)
- Mahdi Fatemizadeh, Farideh Ghavasi, Benyamin Siran Hesari, Iman Akbarzadeh, Nasim Nadi Moghadam, Masoomeh Shirzad, The Role of Acceptance and Commitment-based Group Therapy on Pain Tolerance and State-trait Anxiety in Gastrointestinal Cancer Patients , Journal of Analytical Oncology: Vol. 8 (2019)
- Abdelkrim Berroukche, Malika Bendahmane-Salmi, Badreddine Abdelkrim Kandouci, Biological and Pathological Study of Prostate Cancer at Localized Stage in Western Algeria , Journal of Analytical Oncology: Vol. 2 No. 2 (2013)
- Kenji Ina, Ryuichi Furuta, Tomoko Nishio, Satoshi Kayukawa, Takae Kataoka, Haruhito Totani, Takashi Kanamori, Takaki Kikuchi, Shun Umeda, Tamio Fujita, Pathological Complete Response Induced by the Combination Therapy of Gemcitabine and 24-h Infusion of Cisplatin in Two Cases Initially Diagnosed as Node-Positive Advanced Urothelial Carcinomas , Journal of Analytical Oncology: Vol. 2 No. 4 (2013)
- Arunima Ghosh, Karlena Lara-Otero, Marston W. Linehan , Maria J. Merino , Can Mutations in the BAP1 Gene be Detected by Immunohisto-chemistry in Hereditary Kidney Cancers? , Journal of Analytical Oncology: Vol. 3 No. 3 (2014)
- Tatiana Levkovich, Theofilos Poutahidis, Kelsey Cappelle, Mark B. Smith, Allison Perrotta, Eric J. Alm , Susan E. Erdman , ‘Hygienic’ Lymphocytes Convey Increased Cancer Risk , Journal of Analytical Oncology: Vol. 3 No. 3 (2014)
- Abigail Ruiz de Lobera, Aitziber Buqué, Alberto Muñoz, Sergio Carrera, Aintzane Sancho, Itziar Rubio, Eddy I. Gutierrez, Mikel Arruti, Inés Marrodán, Guillermo López-Vivanco, Bevacizumab in Combination with FOLFIRI in the First-Line Treatment of Patients with Advanced Colorectal Cancer: A Single-Institution Experience , Journal of Analytical Oncology: Vol. 3 No. 1 (2014)
You may also start an advanced similarity search for this article.
Most read articles by the same author(s)
- Rajesh Javarappa, Ramesh Bilimagga, V. Chendil, B.R. Kiran Kumar, Amrut S. Kadam, Acute Haematological Variations in Patients Receiving Radiotherapy and its Correlation with Volume of the Bone Marrow and Radiation Dose , Journal of Analytical Oncology: Vol. 9 (2020)
- Hashmath Khanum, Iqbal Ahmed, V. Chendil, Rajesh Javarappa, Amrut Kadam, Role of Oral Glutamine in Prevention and Treatment of Oral Mucositis in Head and Neck Cancer Patients Receiving Chemoradiation , Journal of Analytical Oncology: Vol. 8 (2019)